Long-lasting reduction of amphetamine-induced hyperactivity in rats after combined administration of caerulein with haloperidol.
D000661:Amphetamine / Q000037:antagonists & inhibitors*; D000818:Animals; D002108:Ceruletide / Q000494:pharmacology*; D006220:Haloperidol / Q000494:pharmacology*; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
D002108:Ceruletide; D000661:Amphetamine; D006220:Haloperidol